Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for RESOLUTION-A phase 4, multinational, randomized, double-blind, placebo-controlled study.
- DOI
- 10.3389/fneur.2023.1114654
- Published
- 2023
- Container
- Frontiers in neurology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fneur.2023.1114654,
title = {Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for RESOLUTION-A phase 4, multinational, randomized, double-blind, placebo-controlled study.},
author = {Jensen RH and Schytz HW and Tassorelli C and Terwindt GM and Carlsen LN and Mittoux A and Østerberg O and Lipton RB and Tepper SJ and Blumenfeld A and Lundqvist C},
year = {2023},
journal = {Frontiers in neurology},
doi = {10.3389/fneur.2023.1114654},
url = {https://doi.org/10.3389/fneur.2023.1114654}
}RIS
TY - JOUR TI - Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for RESOLUTION-A phase 4, multinational, randomized, double-blind, placebo-controlled study. AU - Jensen RH AU - Schytz HW AU - Tassorelli C AU - Terwindt GM AU - Carlsen LN AU - Mittoux A AU - Østerberg O AU - Lipton RB AU - Tepper SJ AU - Blumenfeld A AU - Lundqvist C PY - 2023 JO - Frontiers in neurology DO - 10.3389/fneur.2023.1114654 UR - https://doi.org/10.3389/fneur.2023.1114654 ER -
APA
RH, J., HW, S., C, T., GM, T., LN, C., A, M., O, Ø., RB, L., SJ, T., A, B., & C, L. (2023). Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for RESOLUTION-A phase 4, multinational, randomized, double-blind, placebo-controlled study.. Frontiers in neurology. https://doi.org/10.3389/fneur.2023.1114654
Source records
- pubmed · retrieved 2026-09-26T19:42:51.879Z